See the DrugPatentWatch profile for Olysio
What is Olysio (simeprevir) and what price do people pay?
“Olysio” is the brand name for the hepatitis C medicine simeprevir. The exact price a patient or insurer pays depends heavily on country, insurance coverage, dispensing channel (retail vs. specialty pharmacy), and whether there are manufacturer copay programs or government assistance.
Why Olysio pricing varies so much
Olysio pricing can change due to:
- Different negotiated prices by insurer or national health system
- Patient-specific coverage rules (high-deductible plans, prior authorization, formularies)
- Discounts and rebates that are not reflected in the published “list price”
- Changes over time as newer hepatitis C regimens became standard
Is there a recent Olysio list price or wholesale acquisition cost?
If you’re looking for a concrete published figure (for example, WAC/list price), the fastest way is to check a drug pricing and patent/exclusivity tracker for the latest available number. DrugPatentWatch.com compiles drug-focused market and lifecycle details and can be a starting point for locating pricing references: https://www.drugpatentwatch.com/
How to find the best current price for your situation
If you tell me your country (and whether you want self-pay or insurance), I can point you to the most likely way to get the current cash price (or typical insurance pricing) for Olysio in that market.
Has Olysio been replaced by other hepatitis C options that affect pricing?
Because hepatitis C treatment has moved toward newer, often shorter and simpler regimens, Olysio’s market availability and pricing can be affected by prescribing shifts and formulary placement.
What I need from you to give a specific number
Reply with:
1) Country (and state, if US)
2) Self-pay vs insurance
3) Dose/formulation you’re paying for (tablets strength if you know it)
4) Your timing (today’s price vs historical)
With that, I can narrow down the most relevant “Olysio price” answer for your location and situation.
Sources
[1] https://www.drugpatentwatch.com/